Toxicity and outcome of intensive chemotherapy for acute lymphoblastic leukemia complicated with Turner's syndrome.

Abstract

A 17-year-old woman was diagnosed as acute lymphoblastic leukemia (ALL). As she had chromosomal abnormalities of 44, XO, der(9)t(3;9)(q11;p13), der(10;19)(q10;p10), del(15)(q15), -16, -19, +22 with the presence of ovarian dysplasia and abnormal physical features, a diagnosis of Turner's syndrome was made. She received an induction chemotherapy, which consisted of daunorubicin, cyclophosphamide, vincristine, L-asparaginase and prednisolone. Although, severe liver dysfunction was observed, the patient achieved a complete remission (CR) on day 31 following chemotherapy and has maintained CR for more than five years. The recording of such cases may well be of value to clarify toxicity and outcome after chemotherapy for patients with ALL complicated with Turner's syndrome.

• Authors: Takeshi Saito, Noriko Usui, Osamu Asai, Shingo Yano, Katsuki Sugiyama, Mamoru Hisatomi, Kyoko Ueda, Nobuaki Dobashi, Masayuki Kobayashi
• Journal: Internal medicine (Tokyo, Japan) (Intern Med) Vol. 44 Issue 2 Pg. 145-8 (Feb 2005) ISSN: 0918-2918 [Print] Japan
• PMID: 15750276 (Publication Type: Case Reports, Journal Article)

Topics

• Adolescent
• Antineoplastic Combined Chemotherapy Protocols (administration & dosage, adverse effects)
• Chromosomes, Human, X (genetics)
• Diagnosis, Differential
• Dose-Response Relationship, Drug
• Female
• Follow-Up Studies
• Humans
• Karyotyping
• Liver (drug effects)
• Precursor Cell Lymphoblastic Leukemia-Lymphoma (complications, drug therapy)
• Remission Induction
• Sex Chromosome Aberrations
• Treatment Outcome
• Turner Syndrome (complications, diagnosis, genetics)